65,437 trials
Non-Hodgkin's Lymphoma
Primary: Percentage of Participants With a Complete Remission (CR) or Partial Remission (PR) — 39.5 percentage of participants
Raynaud · Scleroderma
Primary: The Time to Recover 50% of Fall in the Baseline Skin Temperature. — 7.5; 8.2; 7.9 minutes
Staphylococcus Aureus · MRSA Skin Infections · Staphylococcal Skin Infections
Primary: Incidence of Skin and Soft Tissue Infection (SSTI) — 303; 439; 461 participants
Safety of the ProMRI Pacemaker System Under Specific MRI Conditions
Primary: MRI and Pacing System Related Serious Adverse Device Effect (SADE) Free Rate — 100 percentage of participants
Dry Eye Syndrome
Primary: Ocular Comfort Measured as Mean Change From Baseline in OSDI Score by Visit — -7.85; -12.58; -10.23; -16.74 units on a scale
Skin Closure of Surgical Incisions by Tissue Glue vs Suture
Primary: Wound Healing by Numerical Scales for Rubor Postoperative Day 2. — 0.516; 0.984 units on a scale
HIV Infection
Primary: The Rate of Neuropsychiatric and Central Nervous System (CNS) Toxicity of Raltegravir Therapy After 4 Weeks on Treatment — 26 percentage improvement in CNS score
Angina Pectoris · Coronary Artery Disease · Type 2 Diabetes Mellitus
Primary: Average Weekly Angina Frequency Over the Last 6 Weeks of Treatment — 5.2; 4.5 angina attacks per week — p=0.008
Irritable Bowel Syndrome
Primary: Change From Baseline in Irritable Bowel Syndrome Quality Of Life Overall Score — 13.8; 8.4 units on a scale — p=0.0008
Glioblastoma
Primary: Overall Survival (OS) Time — 26.3; 26.3 Months — p=0.8623
Blepharitis
Primary: Visual Analogue Scale (VAS - Ranges 0-100 mm) — 36.5; 28.5 units on a scale (from 0 to 100 mm) — p=0.072
Alcohol Abuse
Primary: Reduced Alcohol Use — 14.96; 15.52 Days drinking
Insomnia
Primary: Cortisol Response to the Dex/CRH Test Post-treatment (6 Weeks Oral Drug) — 108.98 nmol/L
Lung Cancer
Primary: Counts of ≥ Grade 3 Adverse Events (AE) Graded by CTCAE v4 (Common Terminology Criteria for Adverse Events) That Are Definitely, Probably, or Possibly Related to…
Rheumatoid Arthritis
Primary: Percentage of Participants With An American College of Rheumatology 20 Percent (%) Improvement Criteria (ACR20) Response at Week 24 — 47.5 percentage of participants